140.17 USD
-0.27 (-0.19%)
140.17 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to WGS. WGS was compared to 102 industry peers in the Health Care Providers & Services industry. While WGS has a great health rating, there are worries on its profitability. WGS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
WGS had positive earnings in the past year.
In the past year WGS had a positive cash flow from operations.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
WGS has a Return On Assets (0.42%) which is in line with its industry peers.
WGS has a Return On Equity of 0.71%. This is comparable to the rest of the industry: WGS outperforms 54.90% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.94%, WGS is in line with its industry, outperforming 44.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROIC | 1.94% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WGS's Profit Margin of 0.52% is in line compared to the rest of the industry. WGS outperforms 51.96% of its industry peers.
The Operating Margin of WGS (2.48%) is comparable to the rest of the industry.
WGS has a Gross Margin of 69.65%. This is amongst the best in the industry. WGS outperforms 87.25% of its industry peers.
WGS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WGS is destroying value.
The number of shares outstanding for WGS has been increased compared to 1 year ago.
The number of shares outstanding for WGS has been increased compared to 5 years ago.
The debt/assets ratio for WGS has been reduced compared to a year ago.
2.2 Solvency
WGS has an Altman-Z score of 9.46. This indicates that WGS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.46, WGS belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
WGS has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as WGS would need 3.37 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.37, WGS is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that WGS is not too dependend on debt financing.
The Debt to Equity ratio of WGS (0.18) is better than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Altman-Z | 9.46 |
ROIC/WACC0.22
WACC8.94%
2.3 Liquidity
A Current Ratio of 2.71 indicates that WGS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.71, WGS belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
WGS has a Quick Ratio of 2.59. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Quick ratio of 2.59. This is amongst the best in the industry. WGS outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 274.07% over the past year.
The Revenue has grown by 50.50% in the past year. This is a very strong growth!
WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.26% yearly.
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
3.2 Future
Based on estimates for the next years, WGS will show a very strong growth in Earnings Per Share. The EPS will grow by 79.55% on average per year.
Based on estimates for the next years, WGS will show a very strong growth in Revenue. The Revenue will grow by 26.73% on average per year.
EPS Next Y506%
EPS Next 2Y52.56%
EPS Next 3Y94.15%
EPS Next 5Y79.55%
Revenue Next Year47.11%
Revenue Next 2Y34.8%
Revenue Next 3Y29.85%
Revenue Next 5Y26.73%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 74.56, the valuation of WGS can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of WGS is on the same level as its industry peers.
WGS is valuated expensively when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 261.85, which means the current valuation is very expensive for WGS.
Based on the Price/Forward Earnings ratio, WGS is valued a bit more expensive than 61.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.01. WGS is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.56 | ||
| Fwd PE | 261.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WGS is valued a bit more expensive than the industry average as 63.73% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WGS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 258.86 | ||
| EV/EBITDA | 113.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WGS's earnings are expected to grow with 94.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y52.56%
EPS Next 3Y94.15%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
140.17
-0.27 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.95%
Inst Owner Change-4.76%
Ins Owners1.48%
Ins Owner Change-0.1%
Market Cap4.05B
Revenue(TTM)402.19M
Net Income(TTM)2.08M
Analysts83.08
Price Target164.11 (17.08%)
Short Float %14.17%
Short Ratio6.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)200.04%
Min EPS beat(2)14.73%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)260.69%
Min EPS beat(4)14.73%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)161.06%
EPS beat(12)9
Avg EPS beat(12)102.92%
EPS beat(16)12
Avg EPS beat(16)78.7%
Revenue beat(2)2
Avg Revenue beat(2)14.71%
Min Revenue beat(2)10.43%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)12.86%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)13.89%
Revenue beat(12)11
Avg Revenue beat(12)9.25%
Revenue beat(16)14
Avg Revenue beat(16)5.95%
PT rev (1m)24.08%
PT rev (3m)30.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.11%
EPS NY rev (1m)-18.55%
EPS NY rev (3m)-10.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)3.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.56 | ||
| Fwd PE | 261.85 | ||
| P/S | 10.07 | ||
| P/FCF | 258.86 | ||
| P/OCF | 121.4 | ||
| P/B | 13.86 | ||
| P/tB | 37.9 | ||
| EV/EBITDA | 113.36 |
EPS(TTM)1.88
EY1.34%
EPS(NY)0.54
Fwd EY0.38%
FCF(TTM)0.54
FCFY0.39%
OCF(TTM)1.15
OCFY0.82%
SpS13.92
BVpS10.11
TBVpS3.7
PEG (NY)0.15
PEG (5Y)N/A
Graham Number20.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROCE | 2.45% | ||
| ROIC | 1.94% | ||
| ROICexc | 3.13% | ||
| ROICexgc | 11.96% | ||
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% | ||
| FCFM | 3.89% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 72.79% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 1.83 | ||
| Cash Conversion | 97.25% | ||
| Profit Quality | 750.55% | ||
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 9.46 |
F-Score8
WACC8.94%
ROIC/WACC0.22
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
EPS Next Y506%
EPS Next 2Y52.56%
EPS Next 3Y94.15%
EPS Next 5Y79.55%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
Revenue Next Year47.11%
Revenue Next 2Y34.8%
Revenue Next 3Y29.85%
Revenue Next 5Y26.73%
EBIT growth 1Y117.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year534.85%
EBIT Next 3Y123%
EBIT Next 5YN/A
FCF growth 1Y107.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.52%
OCF growth 3YN/A
OCF growth 5YN/A
GENEDX HOLDINGS CORP / WGS FAQ
Can you provide the ChartMill fundamental rating for GENEDX HOLDINGS CORP?
ChartMill assigns a fundamental rating of 5 / 10 to WGS.
What is the valuation status of GENEDX HOLDINGS CORP (WGS) stock?
ChartMill assigns a valuation rating of 3 / 10 to GENEDX HOLDINGS CORP (WGS). This can be considered as Overvalued.
What is the profitability of WGS stock?
GENEDX HOLDINGS CORP (WGS) has a profitability rating of 3 / 10.
What is the financial health of GENEDX HOLDINGS CORP (WGS) stock?
The financial health rating of GENEDX HOLDINGS CORP (WGS) is 7 / 10.
What is the expected EPS growth for GENEDX HOLDINGS CORP (WGS) stock?
The Earnings per Share (EPS) of GENEDX HOLDINGS CORP (WGS) is expected to grow by 506% in the next year.